Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Paeds Topicsnephrology-urology-fluids-and-electrolytes

Paeds · nephrology-urology-fluids-and-electrolytes

Kidney transplantation in children

Also known as Paediatric renal transplantation · Kidney transplant in children · Preemptive kidney transplant · Living donor kidney transplant

Fellowship guide to paediatric kidney transplantation: why a transplanted kidney is the treatment of choice over lifelong dialysis for a child with end-stage kidney disease; the living-donor versus deceased-donor and preemptive versus dialysis-first classifications that predict graft survival; the standard tacrolimus, mycophenolate and steroid maintenance regimen with therapeutic drug monitoring; the distinction between T-cell-mediated and antibody-mediated rejection and how each is treated; and the leading threats to long-term graft survival including non-adherence in adolescence and chronic antibody-mediated rejection.

high12 referencesUpdated 15 July 202625 min readVerification in progress

Practise this topic

  • SAQ
  • Viva
  • Case

Your progress

Saved on this device.

Practise this topic

  • Short-answer question1
  • Viva station1
  • Clinical case1

Target exams

RACP DWERACP DCEMRCPCH TheoryMRCPCH ClinicalABP General Pediatrics

Red flags

  • Sudden oliguria and a swollen tender graft in the early post-operative period suggesting renal vessel thrombosis and imminent graft loss
  • A rising creatinine in a transplanted child that may represent acute rejection, calcineurin inhibitor toxicity, obstruction or recurrence of original disease
  • Early and massive proteinuria within hours of transplant suggesting recurrence of focal segmental glomerulosclerosis requiring urgent plasmapheresis
  • Fever with a rising EBV viral load in an EBV-mismatched recipient suggesting evolving post-transplant lymphoproliferative disorder
  • Rising creatinine with a high BK virus load suggesting BK nephropathy that mimics acute rejection
  • An adolescent with erratic tacrolimus levels, missed clinic visits and graft dysfunction suggesting non-adherence as the cause of late rejection
  • Severe hypovolaemia or hypotension in the early post-operative period precipitating delayed graft function and acute tubular necrosis

Life stages

infanttoddlerpreschoolschool-ageadolescentyoung-adult-transition

Care settings

outpatientwardpicutelehealth

Clinical exam formats

written-onlyracp-dce-long-caseracp-dce-short-casemrcpch-history-managementmrcpch-communicationrcpsc-structured-oral

Board mappings

  • Recognises kidney transplantation as the treatment of choice for end-stage kidney disease in children and outlines donor source and timing classification
  • Identifies the standard maintenance immunosuppression regimen and the need for lifelong follow-up
  • Refers children with advanced chronic kidney disease to a transplant centre early and considers preemptive living-donor transplant
  • Justifies the choice of induction and maintenance immunosuppression based on immunological risk and explains calcineurin inhibitor pharmacology and monitoring
  • Distinguishes T-cell-mediated from antibody-mediated rejection and manages each appropriately, including recurrent disease and BK nephropathy
  • Leads adolescent transition, manages non-adherence, and addresses the long-term complications of chronic immunosuppression including PTLD and post-transplant diabetes
  • Classification of kidney transplantation by donor source and timing, preemptive versus dialysis-first
  • Standard maintenance immunosuppression and the role of therapeutic drug monitoring
  • Causes of graft dysfunction in a transplanted child and the principles of investigation
  • Assesses and investigates a rising creatinine in a paediatric kidney transplant recipient
  • Counsels a family on living-donor versus deceased-donor transplant and the benefits of preemptive transplantation
  • Manages an adolescent transplant recipient with suspected non-adherence and graft dysfunction
  • Level 1: Recognises kidney transplant as the preferred treatment for end-stage kidney disease in children
  • Level 2: Outlines immunosuppression principles and the common early complications of transplantation
  • Level 3: Manages graft dysfunction, rejection and long-term complications, and leads transition to adult care
  • Indications for kidney transplantation in children and the leading causes of paediatric end-stage kidney disease
  • Classification into living versus deceased donor and preemptive versus dialysis-first
  • The standard immunosuppression regimen and the timeline of post-transplant infections including PTLD
  • Assessment and investigation of graft dysfunction in a child after kidney transplant
  • Interpretation of a creatinine rise with tacrolimus trough and donor-specific antibody results
  • Structured explanation of induction, maintenance immunosuppression and rejection treatment
  • Recognition of kidney transplantation as optimal renal replacement therapy for children with end-stage kidney disease
  • Principles of induction and maintenance immunosuppression including tacrolimus therapeutic monitoring
  • Diagnosis and management of acute rejection, infection and post-transplant lymphoproliferative disorder
  • Recognises the indications for and benefits of paediatric kidney transplantation
  • Initiates appropriate workup and referral for transplant including vaccination and tissue typing
  • Identifies graft dysfunction and the common complications of chronic immunosuppression
  • Canadian approach to paediatric kidney transplant candidate selection and donor source
  • Immunosuppression protocols and the management of rejection and opportunistic infection
  • Long-term surveillance, growth, transition and graft-loss prevention strategies
On this page
Study tools

Your progress

Saved on this device.

Practise this topic

  • Short-answer question1
  • Viva station1
  • Clinical case1

Target exams

RACP DWERACP DCEMRCPCH TheoryMRCPCH ClinicalABP General Pediatrics

Red flags

  • Sudden oliguria and a swollen tender graft in the early post-operative period suggesting renal vessel thrombosis and imminent graft loss
  • A rising creatinine in a transplanted child that may represent acute rejection, calcineurin inhibitor toxicity, obstruction or recurrence of original disease
  • Early and massive proteinuria within hours of transplant suggesting recurrence of focal segmental glomerulosclerosis requiring urgent plasmapheresis
  • Fever with a rising EBV viral load in an EBV-mismatched recipient suggesting evolving post-transplant lymphoproliferative disorder
  • Rising creatinine with a high BK virus load suggesting BK nephropathy that mimics acute rejection
  • An adolescent with erratic tacrolimus levels, missed clinic visits and graft dysfunction suggesting non-adherence as the cause of late rejection
  • Severe hypovolaemia or hypotension in the early post-operative period precipitating delayed graft function and acute tubular necrosis

Life stages

infanttoddlerpreschoolschool-ageadolescentyoung-adult-transition

Care settings

outpatientwardpicutelehealth

Clinical exam formats

written-onlyracp-dce-long-caseracp-dce-short-casemrcpch-history-managementmrcpch-communicationrcpsc-structured-oral

Board mappings

  • Recognises kidney transplantation as the treatment of choice for end-stage kidney disease in children and outlines donor source and timing classification
  • Identifies the standard maintenance immunosuppression regimen and the need for lifelong follow-up
  • Refers children with advanced chronic kidney disease to a transplant centre early and considers preemptive living-donor transplant
  • Justifies the choice of induction and maintenance immunosuppression based on immunological risk and explains calcineurin inhibitor pharmacology and monitoring
  • Distinguishes T-cell-mediated from antibody-mediated rejection and manages each appropriately, including recurrent disease and BK nephropathy
  • Leads adolescent transition, manages non-adherence, and addresses the long-term complications of chronic immunosuppression including PTLD and post-transplant diabetes
  • Classification of kidney transplantation by donor source and timing, preemptive versus dialysis-first
  • Standard maintenance immunosuppression and the role of therapeutic drug monitoring
  • Causes of graft dysfunction in a transplanted child and the principles of investigation
  • Assesses and investigates a rising creatinine in a paediatric kidney transplant recipient
  • Counsels a family on living-donor versus deceased-donor transplant and the benefits of preemptive transplantation
  • Manages an adolescent transplant recipient with suspected non-adherence and graft dysfunction
  • Level 1: Recognises kidney transplant as the preferred treatment for end-stage kidney disease in children
  • Level 2: Outlines immunosuppression principles and the common early complications of transplantation
  • Level 3: Manages graft dysfunction, rejection and long-term complications, and leads transition to adult care
  • Indications for kidney transplantation in children and the leading causes of paediatric end-stage kidney disease
  • Classification into living versus deceased donor and preemptive versus dialysis-first
  • The standard immunosuppression regimen and the timeline of post-transplant infections including PTLD
  • Assessment and investigation of graft dysfunction in a child after kidney transplant
  • Interpretation of a creatinine rise with tacrolimus trough and donor-specific antibody results
  • Structured explanation of induction, maintenance immunosuppression and rejection treatment
  • Recognition of kidney transplantation as optimal renal replacement therapy for children with end-stage kidney disease
  • Principles of induction and maintenance immunosuppression including tacrolimus therapeutic monitoring
  • Diagnosis and management of acute rejection, infection and post-transplant lymphoproliferative disorder
  • Recognises the indications for and benefits of paediatric kidney transplantation
  • Initiates appropriate workup and referral for transplant including vaccination and tissue typing
  • Identifies graft dysfunction and the common complications of chronic immunosuppression
  • Canadian approach to paediatric kidney transplant candidate selection and donor source
  • Immunosuppression protocols and the management of rejection and opportunistic infection
  • Long-term surveillance, growth, transition and graft-loss prevention strategies

Overview & Definition

A child whose kidneys have failed has end-stage kidney disease, and the question becomes how to replace what the kidneys did. There are two ways: dialysis, which filters the blood by machine or through the abdomen, or a kidney transplant, in which a healthy kidney from a donor is surgically placed in the child's lower abdomen. A transplanted kidney is the treatment of choice for almost every child with end-stage kidney disease, because it does what dialysis cannot: it works continuously, frees the child from the machine, restores near-normal growth and development, and improves long-term survival. [1]

The new kidney does not replace the old ones. The child's own failed kidneys usually stay in place, and the donor kidney is placed in the iliac fossa, the lower abdomen, where its blood vessels are joined to the large pelvic vessels and its ureter is connected to the bladder. The operation is the easy part. The hard part, which dominates everything afterwards, is that the child's immune system sees the donor kidney as foreign and will attack and destroy it unless the child takes immunosuppressant medicines every single day for life. This balance, between protecting the graft and avoiding the infections and cancers that immunosuppression permits, is what paediatric transplant medicine is about. [2]

One-sentence definition for the exam

Kidney transplantation is the surgical placement of a donor kidney into a child with end-stage kidney disease; it is the treatment of choice over lifelong dialysis because it restores near-normal physiology, growth and survival, and it requires lifelong immunosuppression to prevent the immune system from rejecting the graft. The graft is classified by donor source (living versus deceased) and by timing (preemptive before dialysis versus dialysis-first), and is protected by a standard regimen of tacrolimus, mycophenolate and a minimised steroid. [1]

Paediatrics Fellowship Pro

Continue reading

You have read the opening of this topic. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship library.

Sign in to continueSee pricing
References12ShowHide
  1. [1]Roach JP, Bock ME, Goebel J Pediatric kidney transplantation. Semin Pediatr Surg, 2017.PMID 28964479
  2. [2]Holmberg C, Jalanko H Long-term effects of paediatric kidney transplantation. Nat Rev Nephrol, 2016.PMID 26656457
  3. [3]Winterberg PD, Garro R Long-Term Outcomes of Kidney Transplantation in Children. Pediatr Clin North Am, 2019.PMID 30454748
  4. [4]Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant, 2009.PMID 19845597
  5. [5]Chadban SJ, Barraclough KA, Campbell SB, et al KHA-CARI guideline: KHA-CARI adaptation of the KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients. Nephrology (Carlton), 2012.PMID 22212251
  6. [6]Kizilbash SJ, Jensen CJ, Kouri AM, et al Steroid avoidance/withdrawal and maintenance immunosuppression in pediatric kidney transplantation. Pediatr Transplant, 2022.PMID 34786800
  7. [7]Balani SS, Jensen CJ, Kouri AM, et al Induction and maintenance immunosuppression in pediatric kidney transplantation-Advances and controversies. Pediatr Transplant, 2021.PMID 34216190
  8. [8]Weber LT Therapeutic drug monitoring in pediatric renal transplantation. Pediatr Nephrol, 2015.PMID 24763544
  9. [9]Ng YW, Singh M, Sarwal MM Antibody-mediated rejection in pediatric kidney transplantation: pathophysiology, diagnosis, and management. Drugs, 2015.PMID 25813498
  10. [10]Ashoor IF, Engen RM, Puliyanda D, et al Antibody-mediated rejection in pediatric kidney transplant recipients: A report from the Pediatric Nephrology Research Consortium. Pediatr Transplant, 2024.PMID 38602171
  11. [11]Scaggs Huang FA, Danziger-Isakov L Infectious disease risks in pediatric renal transplantation. Pediatr Nephrol, 2019.PMID 29626241
  12. [12]Holmberg C Nonadherence after pediatric renal transplantation: detection and treatment. Curr Opin Pediatr, 2019.PMID 30672821

Test yourself

Practise what you just read

  • SAQ
  • Viva
  • Case
Paediatrics Fellowship Pro

$29/ monthor $279 / year

The complete Paediatrics Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousKidney replacement therapy and dialysis in childrennephrology-urology-fluids-and-electrolytesNextLupus nephritis and systemic diseasenephrology-urology-fluids-and-electrolytes